Shares of AbbVie Inc. ABBV slid 3.14% to $174.20 Thursday, on what proved to be an all-around dismal trading session for the ...

Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), The TJX Companies, Inc ...

We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend ...

Best Stocks for 15 Years. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best stocks for 15 years. Russell Investments believes that 3 features are ...

We recently published a list of the 10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to ...

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 ...

Shares of AbbVie Inc. ABBV slid 5.83% to $175.67 Tuesday, on what proved to be an all-around poor trading session for the ...

The EC has granted marketing authorisation for AbbVie's once-a-day treatment Rinvoq (upadacitinib) 15mg for adults with GCA.

Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Ongoing economic uncertainty, concerns about recession, inflationary pressure, and tariff pause have made investors switch to ...

The 340B program requires drugmakers who want to participate in Medicaid and Medicare to discount their prices for hospitals, clinics and other providers that serve low-income patients. Those “covered ...

Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) dropped 0.2% during trading on Thursday after an insider sold shares in the company. The stock traded as low as $204.55 and last traded at $204.69.